#novonordisk — Public Fediverse posts

https://www.europesays.com/dk/81882/ Novo Nordisk Restructures Domestic Footprint as Oral Wegovy Pill Outpaces Rival #domestic #footprint #Nordisk #novo #NovoNordisk #Oral #Outpaces #pill #Restructures #Rival #Wegovy

https://www.europesays.com/dk/81829/ Novo Nordisk Tightens Operations as Oral Wegovy Pill Sales Double Expectations #double #Expectations #Nordisk #novo #NovoNordisk #operations #Oral #pill #sales #Tightens #Wegovy

https://www.europesays.com/dk/81747/ Novo Nordisk Highlights New Wegovy Pill Data – Novo Nordisk (NYSE:NVO) #Category:Biotech #Category:General #Category:HealthCare #Category:LargeCap #Category:News #CMS:WordPress #NovoNordisk #PageIsBzPro:BZ #Symbol:NVO #Tag:WeightLoss

https://www.europesays.com/dk/81586/ Novo Nordisk’s Oral Wegovy Pill Defies Expectations as Data Blitz Reshapes Obesity Market Battle #Blitz #data #defies #Expectations #Nordisk’s #novo #NovoNordisk #Oral #pill #Reshapes #Wegovy

https://www.europesays.com/dk/81571/ Novo Nordisk Balances Canadian Price Pressure With Sickle Cell Advance and Oral Pill Triumph #Advance #Balances #Canadian #cell #Nordisk #novo #NovoNordisk #pressure #price #Sickle #with

https://www.europesays.com/dk/81487/ Menopause Heart Data, Oral Pill Revenue Double, and a Parkinso #data #Flexes #heart #menopause #Metabolic #Muscle #Nordisk #novo #NovoNordisk #Oral #pill

https://www.europesays.com/dk/81467/ Novo Nordisk’s Wegovy Pill Boosts Mobility in 8 of 10 Patients as Quarterly Sales Surge Past Expec #Boosts #mobility #Nordisk’s #novo #NovoNordisk #patients #pill #Quarterly #sales #surge #Wegovy

https://www.europesays.com/dk/81273/ Novo Nordisk’s Oral Wegovy Sales Surprise Caps Strong Data Showing at Istanbul Obesity Congress #Caps #data #Nordisk’s #novo #NovoNordisk #Oral #sales #Showing #strong #Surprise #Wegovy

https://www.europesays.com/dk/81253/ Fat-Loss Data Impress as Oral Wegovy Sales Double Expectations #data #double #FatLoss #Impress #Nordisk #novo #NovoNordisk #Oral #scores #Wegovy #win

https://www.europesays.com/dk/80757/ How Novo Nordisk’s CFO Is Rebuilding Growth #AI #CFO #CFOTurnover #ConsumerConfidence #ECONOMY #inflation #KarstenMunkKnudsen #NovoNordisk #RussellReynoldsAssociates #SECQuarterlyReports

https://www.europesays.com/dk/80679/ Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons #A/S #and #associated #board #by #executives #in #Members #Nordisk #novo #NovoNordisk #persons #shares #Trading

https://www.europesays.com/dk/80473/ Novo Nordisk A/S: Wegovy® delivered substantial weight loss in women across all menopause stages, plus heart and migraine protection, shown in new Novo Nordisk data at the European Congress on Obesity #A/S #Across #All #and #at #congress #data #delivered #european #heart #in #Loss #menopause #migraine #new #Nordisk #novo #NovoNordisk #Obesity #on #plus #protection #shown #stages #substantial #the #Wegovy #Weight #women

https://www.europesays.com/dk/80292/ Novo Nordisk A/S: Higher dose Wegovy® demonstrates nearly 28% weight loss in early responders according to new analyses presented at the European Congress on Obesity #28% #A/S #according #analyses #at #congress #demonstrates #dose #early #european #higher #in #Loss #nearly #new #Nordisk #novo #NovoNordisk #Obesity #on #presented #responders #the #to #Wegovy #Weight

https://www.europesays.com/no/235600/ – En oppvåkning – E24 #aker #Business #Economy #JonasGahrStøre #kone #KristinSkogenLund #Næringsliv #NO #nordea #norden #Norge #Norway #NovoNordisk #WallenbergFamilien

https://www.europesays.com/dk/80192/ Novo Nordisk’s Oral Wegovy Smashes Expectations, but Margin Pressure and Rival Threats Cloud the O #Cloud #Expectations #Nordisk’s #novo #NovoNordisk #Oral #pressure #Rival #Smashes #threats #Wegovy

https://www.europesays.com/dk/79993/ Novo gives Parkinson’s therapy to Boston-based Cellular Intelligence #Biotech&Pharma #BloombergNewsExclusives #Danish #Denmark #EU #EMEA #EU #EuroMembers #europe #european #Health #nordic #NovoNordisk #PharmaceuticalDrugs #Scandinavia

https://www.europesays.com/dk/79980/ Novo Nordisk hands a Parkinson’s cell therapy to Cellular Intelligence, a startup trying to design cell behavior #ArtificialIntelligence #Biotechnology #CellTherapy #CellularIntelligence #ClinicalTrials #DopaminergicNeurons #DrugDevelopment #MichaBreakstone #neurology #NovoNordisk #Parkinson'sDisease #SomiteAI #StemCellResearch #STEMPD #VentureCapital

https://www.europesays.com/dk/79324/ Novo Nordisk’s Oral Wegovy Defies Gravity as FDA Poised to Curb Compounders #Compounders #Curb #defies #FDA #Gravity #Nordisk’s #novo #NovoNordisk #Oral #Poised #Wegovy

The Week in Numbers: major profit highs, mega Wegovy sales

From Shell’s major profit surge of $6.9 billion — its highest in two years — to Novo Nordisk’s booming Wegovy sales reshaping the weight loss market, Fiona Jones rounds up the biggest financial stories of the week. #News #Reuters #Newsfeed #globalmarkets #shell #wegovy #novonordisk Read the story here: 👉 Subscribe: Keep up with the latest news from around the world: Follow Reuters on Facebook: Follow Reuters on…

https://fllics.com/en/video/the-week-in-numbers-major-profit-highs-mega-wegovy-sales/

https://www.europesays.com/dk/77475/ These 2 Stocks Have More Upside #EliLilly #NovoNordisk #NYSE #Pfizer

https://www.europesays.com/dk/76600/ Novo Nordisk’s Pill Push Eases the Pain, but the Generics Are Already Circling #Already #are #Circling #Eases #generics #Nordisk’s #novo #NovoNordisk #pain #pill #Push

https://www.europesays.com/dk/75598/ Novo Nordisk Share Price: Obesity Pill Ka Craze Hai, Par Profitability Ki Testing Shuru! #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket

https://www.europesays.com/dk/75463/ Can a Pill and a Buyback Turn the Tide? #billion #Buyback #Can #Nordisk #Nordisk’s #novo #NovoNordisk #pill #Tide #Turn #Wipeout

https://www.europesays.com/dk/75448/ Novo Nordisk’s Obesity Pill Demand Soars, Profitability Faces Tough Test #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket

https://www.europesays.com/dk/?p=74979 Novo Nordisk’s Weight-Loss Pill Fuels Fierce Rivalry with Eli Lilly #EliLilly #MarketShare #NovoNordisk #ObesityDrugs #ObesityTreatment #PharmaceuticalCompetition #PrescriptionGrowth #PricePressures #Wegovy #WeightLossPill

https://www.europesays.com/dk/74353/ Novo Nordisk Puts Oral Ozempic on Pharmacy Shelves Just Days Before a Make-or-Break Earnings Report #Before #days #just #Nordisk #novo #NovoNordisk #Oral #ozempic #pharmacy #Puts #Shelves

https://www.europesays.com/dk/74111/ Oral Ozempic Hits Pharmacies as Earnings Test Investor Patience #earnings #HighStakes #hits #Nordisk’s #novo #NovoNordisk #Oral #ozempic #pharmacies #test #week

https://www.europesays.com/dk/74107/ Generics, Pipeline Wins, and a Pivotal Earnings Report #Crossroads #Crucial #earnings #faces #generics #Nordisk #novo #NovoNordisk #pipeline #Pivotal #wins

https://www.europesays.com/dk/73952/ Is Novo Nordisk A/S (NVO) A Good Stock To Buy Now? #EliLilly #MarketShare #NovoNordisk #PharmaceuticalProducts #UnfairAdvantage

https://www.europesays.com/dk/73654/ Oral Ozempic Arrives as Q1 Results Loom #Arrives #Loom #Nordisk #Nordisk’s #novo #NovoNordisk #Oral #ozempic #Pivotal #results #week

https://www.europesays.com/dk/73591/ FDA Curbs Copycats as Oral Ozempic Hits 70,000 Pharmacies #Copycats #Curbs #FDA #hits #Nordisk’s #novo #NovoNordisk #OneTwo #Oral #ozempic #Punch

https://www.europesays.com/dk/73332/ Novo Nordisk’s Ozempic Pill Hits Shelves as Q1 Earnings Loom and Valuation Debate Deepens #debate #earnings #hits #Loom #Nordisk’s #novo #NovoNordisk #ozempic #pill #Shelves #Valuation

https://www.europesays.com/dk/73271/ Q1 Earnings Loom as Valuation Debate Intensifies #check #debate #earnings #faces #Intensifies #Loom #Nordisk #novo #NovoNordisk #reality #Valuation

https://www.europesays.com/dk/73025/ FDA Curbs Copycats as Ozempic Pill Replaces Rybelsus #Copycats #Curbs #double #FDA #Nordisk’s #novo #NovoNordisk #ozempic #pill #Replaces #win

https://www.europesays.com/dk/72312/ Novo Nordisk’s Hemophilia Data Offers Rare Bright Spot as Revenue Guidance Darkens #Bright #data #guidance #Hemophilia #Nordisk’s #novo #NovoNordisk #Offers #Rare #revenue #Spot

https://www.europesays.com/dk/71476/ Canadian Generic Launch and Q1 Results Loom #Canadian #faces #Generic #Launch #Loom #Nordisk #novo #NovoNordisk #results #tests #Twin

https://www.europesays.com/dk/70445/ Novo Nordisk Juggles Pipeline Wins and Core Business Headwinds #business #Coramitug #core #FDA #Headwinds #Juggles #Nordisk #novo #NovoNordisk #pipeline #wins

https://www.europesays.com/dk/69905/ Novo Nordisk releases 2026 sales and operating profit outlook #CER #JacobMartin #NovoNordisk #OperatingProfit #SalesGrowth

https://www.europesays.com/dk/69824/ Novo Nordisk’s sales increased by 6% in Danish kroner and by 10% at constant exchange rates to DKK 309.1 billion in 2025 #CER #DanishKroner #ExchangeRates #JacobMartin #NovoNordisk #OperatingProfit #SalesGrowth

https://www.europesays.com/dk/69666/ Novo Nordisk’s Pipeline Delivers Two Wins as Stock Sinks to Oversold Territory #delivers #Nordisk’s #novo #NovoNordisk #Oversold #pipeline #Sinks #stock #territory #two #wins

https://www.europesays.com/dk/?p=69503 Novo Nordisk’s Teen Pill Push and Buyback Blitz Come as Oral Wegovy Leaves Lilly in the Dust #Blitz #Buyback #come #Nordisk’s #novo #NovoNordisk #Oral #pill #Push #teen #Wegovy

https://www.europesays.com/dk/69272/ Novo Nordisk’s CagriSema Data Locked as Pipeline Hopes Wrestle With a 50% Stock Wipeout #cagrisema #data #Hopes #Locked #Nordisk’s #novo #NovoNordisk #pipeline #stock #with #Wrestle

https://www.europesays.com/dk/68947/ Novo Nordisk’s Dividend Yield Nears 5% as Washington Shuffle and Medicare Price Caps Reshape the G #Caps #Dividend #Medicare #nears #Nordisk’s #novo #NovoNordisk #price #Shuffle #Washington #Yield

https://www.europesays.com/dk/65646/ Novo Nordisk’s Sickle Cell Drug Delivers as Buyback Program Advances #Advances #Buyback #cell #delivers #drug #Nordisk’s #novo #NovoNordisk #Phase #Program #Sickle

https://www.europesays.com/dk/65180/ Novo Nordisk’s Rare Disease Breakthrough Fails to Lift Oversold Shares #Breakthrough #Disease #Fails #lift #Nordisk #Nordisk’s #novo #NovoNordisk #Oversold #Rare #shares

https://www.europesays.com/dk/65079/ Why Eli Lilly Is Leaving Novo Nordisk in the Dust #EliLilly #HealthcareStocks #MarketValue #NovoNordisk #WeightLoss #WeightManagement

https://www.europesays.com/dk/65065/ Novo Nordisk’s Blood Disorder Breakthrough Offers a Lifeline Amid GLP-1 Gloom #amid #Blood #Breakthrough #disorder #Gloom #GLP1 #Lifeline #Nordisk’s #novo #NovoNordisk #Offers

https://www.europesays.com/dk/63298/ Novo Nordisk’s Wegovy Wins EMA Flexibility In GLP-1 Access Push #EMA #NovoNordisk #Wegovy #WegovyInjection

https://www.europesays.com/dk/58479/ Novo Nordisk’s European Logistics Breakthrough Meets US Pricing Headwinds #Breakthrough #EMA #european #Headwinds #Logistics #Meets #Nordisk’s #novo #NovoNordisk #Pricing #Wegovy

https://www.europesays.com/dk/58417/ New Drugs and a Massive Buyback Amid Market Pressure #amid #Buyback #drugs #dual #market #Massive #new #Nordisk’s #novo #NovoNordisk #strategy